5-Amino-1MQ (10 mg Vial) Dosage Protocol

5-Amino-1MQ Dosage Chart

5-Amino-1MQ is dosed at 2.5 mg–5 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 5 mg/mL. This information is for research and educational use only.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
  • Typical daily range: 2.5–5 mg once or twice daily (subcutaneous).
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels. By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency. This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format.

Subcutaneous, once or twice daily

Subcutaneous Protocol (2 mL = 5 mg/mL)

PhaseDaily Dose (mg)Units (per injection) (mL)
Days 1–2 (Tolerance)2.5 mg (2500 mcg)50 units (0.50 mL)
Days 3+ (Standard)5 mg (5000 mcg)100 units (1.00 mL)
Alternative BID2.5 mg twice daily50 units (0.50 mL) × 2

5-Amino-1MQ is dosed at 2.5 mg–5 mg daily via subcutaneous injection in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 5 mg/mL. This information is for research and educational use only.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
  • Typical daily range: 2.5–5 mg once or twice daily (subcutaneous).
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels. By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency. This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format.